| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Model |
,

**
¶**
§¶**

From the Departments of Pathology,*
Ophthalmology,
Pediatrics,
and Molecular and Cellular
Biology,§
the Center for Cell and Gene
Therapy,¶
The Texas Childrens Cancer
Center,**
and the Retinoblastoma
Center,

Baylor College of
Medicine, Houston, Texas
To generate animal models of retinoblastoma that closely resemble metastatic and nonmetastatic human disease for the purposes of examining tumor biology and developing alternate treatments, human retinoblastoma cell lines were injected into the vitreal cavities of immunodeficient mice. Two reproducible animal models with contrasting biological behaviors analogous to human retinoblastoma have been developed. The Y79 retinoblastoma model demonstrated specific tumor evolution similar to that seen in human invasive and metastatic disease. Y79 retinoblastoma cells formed intraocular tumors that were initially confined to the vitreal cavity. Tumors progressively invaded the retina, subretinal space, choroid, optic nerve head, and anterior chamber of the eye. Tumors progressed into the subarachnoid space and focally invaded the brain. Metastases were detected in the contralateral optic nerve. Large tumors developed extraocular extensions. The histology of the tumors showed a poorly differentiated pattern with high mitotic rate, foci of necrosis, and calcification. The WERI-Rb model more closely resembled nonmetastatic human retinoblastoma. WERI- Rb tumors were localized in the eye with only anterior choroidal invasion at late stages. To examine potential biological differences in vitro, the retinoblastoma cell lines were cocultured with adherent choroid cells or adherent glioma cells which represent the targets of invasive retinoblastoma in vivo. Consistent with the in vivo observations, Y79 cells but not WERI-Rb cells adhere specifically to both the choroidal and the glioma cell lines.
This article has been cited by other articles:
![]() |
L. Wadhwa, M. Y. Hurwitz, P. Chevez-Barrios, and R. L. Hurwitz Treatment of Invasive Retinoblastoma in a Murine Model Using an Oncolytic Picornavirus Cancer Res., November 15, 2007; 67(22): 10653 - 10656. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chintagumpala, P. Chevez-Barrios, E. A. Paysse, S. E. Plon, and R. Hurwitz Retinoblastoma: Review of Current Management Oncologist, October 1, 2007; 12(10): 1237 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Laurie, J. K. Gray, J. Zhang, M. Leggas, M. Relling, M. Egorin, C. Stewart, and M. A. Dyer Topotecan Combination Chemotherapy in Two New Rodent Models of Retinoblastoma Clin. Cancer Res., October 15, 2005; 11(20): 7569 - 7578. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Van Aken, P. Papeleu, Patrick De Potter, E. Bruyneel, J. Philippe, S. Seregard, A. Kvanta, J.-J. De Laey, and M. M. Mareel Structure and Function of the N-Cadherin/Catenin Complex in Retinoblastoma Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 595 - 602. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |